Health News (Reuters)

Bayer, J&J win reversal of $28 million verdict in Xarelto lawsuit

(Reuters) - A Pennsylvania state court judge on Tuesday overturned a $27.8 million jury award to an Indiana couple who accused Bayer AG and Johnson & Johnson of failing to warn of internal bleeding risks of their drug Xarelto, the companies said.

Florida judge blocks abortion delay law, rules it unconstitutional

(Reuters) - A Florida judge on Tuesday permanently blocked and declared unconstitutional a law requiring a woman to delay an abortion by at least 24 hours after making a visit to a doctor who would have to inform her of possible risks of the procedure.

Human antibodies made in cows could be developed to treat MERS

LONDON (Reuters) - Human antibodies made in genetically engineered cows have proved safe in an early stage clinical trial, U.S. scientists said on Wednesday, and could be developed into a treatment for the fatal viral disease, MERS.

Obesity linked with disability after joint surgery

(Reuters Health) - People who undergo joint surgery, such as joint replacements for arthritis, are more likely to become dependent in the years following surgery if they are obese, researchers say.

Bluebird to seek approvals for three treatments by end of 2019

(Reuters) - U.S. biotech bluebird bio Inc, which does not yet have any marketed products, expects to be able to file for regulatory approval of three novel treatments by the end of 2019, chief executive Nick Leschly announced on Tuesday.

Health secretary nominee indicates support for Medicaid overhaul

WASHINGTON (Reuters) - Alex Azar, a former drug industry executive and lobbyist nominated to run the U.S. Department of Health and Human Services, indicated on Tuesday he supported a Republican bid to overhaul Medicaid and again vowed to tackle high drug prices.

Not all elderly lung cancer patients get recommended care

(Reuters Health) - Elderly lung cancer patients who are black or from less educated communities are less likely to get the combination of chemotherapy and radiation that’s linked to better survival odds, a U.S. study suggests.

U.S. lawsuit says Wal-Mart deceived buyers of organic eggs

CHICAGO (Reuters) - Wal-Mart Stores Inc misled U.S. shoppers by selling organic eggs laid by hens raised in enclosed structures under package labels that said the birds had access to the outdoors, a federal lawsuit alleged on Monday.

Severe obesity declining among low-income U.S. kids

(Reuters Health) - The proportion of poor kids receiving government food assistance who are severely obese has declined following benefits changes designed to encourage healthier purchases, a U.S. study suggests.

Shire cuts 2020 revenue target, prepares for spin-off of ADHD drugs

LONDON (Reuters) - Shire ditched its revenue target of $20 billion by 2020 on Monday due to increased generic competition and new drugs from rivals, saying it would split its rare disease and hyperactivity medicines businesses to boost performance.

Celgene 2018 revenue forecast shy of estimates, shares fall

(Reuters) - Celgene Corp , which has announced a deal to buy Impact Biomedicines, on Monday forecast 2018 total revenue that fell short of analysts' estimates, sending the U.S. biotech company's shares down 2 percent.